Pharmafile Logo
Pharmafocus logo
Advanced Search

Roche

Showing 15 posts of 710 posts found.

Roche image

Roche to submit Herceptin successor to regulators

April 2, 2012
Research and Development, Sales and Marketing GSK, Herceptin, Roche, Xeloda

Roche has said it will submit its new breast cancer drug trastuzumab for regulatory review in the US and Europe …

News
GSK image

GSK settles cancer patent dispute

March 28, 2012
Research and Development, Sales and Marketing GSK, Genmab, Roche, ofatumumab, patents

GlaxoSmithKline has settled a long-running patent dispute over its cancer treatment ofatumumab.  The US patents, which relate to recombinant antibody …

News
Zelboraf image

Roche’s melanoma pill launched in UK

March 14, 2012
Sales and Marketing BMS, CDF, NICE, Roche, Yervoy, Zelboraf

Roche’s Zelboraf has been launched in the UK to treat the deadliest form of skin cancer.  Zelboraf (vemurafenib) is the …

News
mark_archer_013

inVentiv appoints former Quintiles man Mark Archer

March 9, 2012
Business Services, Medical Communications, Sales and Marketing Merck, Quintiles, Roche, Sanofi, inVentiv

Pharma consultants inVentiv Health has appointed Mark as its new senior vice president of European operations and development for inVentiv …

Appointment
Roche picture

Indian CMO will make Roche blockbusters

March 6, 2012
Manufacturing and Production Emcure, Herceptin, India, MabThera, Pegasys, Roche

Roche has reportedly signed an agreement with Emcure Pharmaceuticals of India that will see the latter manufacturing its blockbuster drugs …

News
RoActemra image

Roche’s RoActemra beats Humira in arthritis study

March 5, 2012
Research and Development, Sales and Marketing Humira, RA, RoActemra, Roche, arthritis

Roche’s rheumatoid arthritis drug RoActemra has beaten Abbott’s Humira in a head-to-head study. The Phase IV trial showed that RoActemra …

News
Zelboraf image

European approval for Roche’s Zelboraf

February 20, 2012
Sales and Marketing Cancer, Roche, Yervoy, Zelboraf, melanoma

Roche’s skin cancer pill Zelboraf has been given European approval to treat advanced melanoma.  Zelboraf (vemurafenib) is now available in …

News
Tarceva image

NICE no for first line Tarceva

February 17, 2012
Sales and Marketing CDF, Cancer, NICE, Roche, Tarceva

NICE no for first line Tarceva Watchdog wants more information on Roche’s drug NICE is not recommending Roche’s lung cancer …

News
Herceptin and Tyverb image

NICE cannot recommend breast cancer drugs

February 14, 2012
Sales and Marketing GSK, Herceptin, NHS, NICE, Roche, Tyverb

NICE is not recommending GlaxoSmithKline’s Tyverb or Roche’s Herceptin for use in certain breast cancer patients. The watchdog said in …

News
Roche picture

FDA grants Roche’s pertuzumab priority review

February 10, 2012
Sales and Marketing Herceptin, Roche, pertuzumab

The FDA has accepted Roche’s potential breast cancer treatment pertuzumab for appraisal and granted the drug priority review. The proposed …

News

Roche rounds off year with solid performance

February 3, 2012
Sales and Marketing Roche

A strong performance in its diagnostics division was among the factors enabling Roche to deliver a solid set of results …

News

GMP issues affect Mircera, Xenical production at Roche plant

January 31, 2012
Manufacturing and Production GMP, Mircera, Roche, Tamiflu, Xenical

Supply of two Roche products has been disrupted after an active pharmaceutical ingredient (API) production facility in the US was …

News
Roche picture

Roche’s Erivedge gains FDA approval

January 31, 2012
Sales and Marketing Erivedge, FDA, Roche

The FDA has approved Roche’s Erivedge to treat patients with a common form of skin cancer. Erivedge (vismodegib) is now …

News
Roche picture

Roche launches $5.7 billion hostile bid for Illumina

January 25, 2012
Research and Development, Sales and Marketing Diagnostics, Illumina, Roche

Roche has launched a hostile takeover bid for US diagnostics company Illumina. The Swiss manufacturer appears tired of waiting for …

News
Tamiflu image

BMJ blasts Roche for withholding Tamiflu data

January 18, 2012
Research and Development, Sales and Marketing BMJ, EMA, Roche, Tamiflu, WHO

Roche is still withholding Tamiflu data from researchers, claims the British Medical Journal. Two years after Roche said it would …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025